Running title: Wnt pathway activation in NF1 tumorigenesis
INTRODUCTION
Neurofibromatosis type 1 (NF1) is an autosomal dominant neurocutaneous disorder affecting 1 in 3000 individuals worldwide (1) . The NF1 gene is located in the chromosome region 17q11.2. Its protein product, neurofibromin, functions as a negative regulator of RAS proteins. The main clinical features of NF1 are café-au-lait macules, skinfold freckling, iris Lisch nodules, as well as skeletal and cardiovascular abnormalities. NF1 patients have an increased risk of both benign and malignant tumors, therefore, NF1 is classified as a tumor predisposition syndrome. The most common tumors are benign peripheral nerve sheath tumors (neurofibromas), which vary greatly in both number and size, and may be dermal or plexiform (2) .
Dermal neurofibromas are typically small and grow as discrete lesions in the dermis whereas plexiform neurofibromas can develop internally along the plexus of major peripheral nerves and become quite large. Plexiform neurofibromas are probably derived from embryonic termed "skin-derived precursors" that form dermal neurofibromas through loss of Nf1 (5).
These differences between dermal and plexiform neurofibromas suggest that the type of progenitor but also the timing of somatic NF1 mutations may determine the clinical course of these tumors (6) .
In contrast to dermal neurofibromas, plexiform neurofibromas can undergo malignant transformation to malignant peripheral nerve sheath tumors (MPNSTs) in about 10% of NF1 patients (7) . Roughly half of all MPNSTs are sporadic; they are found in patients who do not carry any known genetic predisposition for cancer. The remaining MPNSTs are found in 7 patients who are diagnosed with NF1. MPNSTs are resistant to conventional therapies, and their deep-seated position and locally invasive growth hinder complete surgical resection.
The five-years survival rate among patients with MPNSTs ranges from 30 to 50%. In parallel to the double inactivation of the NF1 gene, additional genetic lesions seem necessary for malignant progression of plexiform neurofibromas. TP53 mutations have been identified in MPNSTs but not in benign neurofibromas, indicating that the p53-mediated pathway is involved in malignant progression (6, 8) . Alterations of other genes (p16/CDKN2A, p14/ARF, p27/KIP1, EGFR, mTOR) were also detected in MPNST (9-12).
Although we have now identified some of the genes that when mutated initiate tumor formation and drive progression, the identity of the cell population(s) susceptible to such transforming events remains undefined in the majority of human cancers. Recent studies indicate that a small population of cells (called cancer stem cells) endowed with unique selfrenewal properties and tumorigenic potential is present in some, and perhaps, all tumors (13) (14) . Many signalling pathways involved in the maintenance of normal stem cells are found to be altered in several human cancers (i.e. Wnt, Hedgehog and Notch pathways). Moreover, several authors addressed the possible association between the formation of stem cells and the epithelial-mesenchymal transition (EMT). Regulation of the EMT is a crucial step in cancer development (15) . Genetic alterations that impair the differentiation program could endow such dedifferentiated cells with attributes that mimic stem cell behaviour.
In NF1 tumorigenesis, the question whether these tumors arise from neural crest stem cells or differentiates glia remains very controversial (4, 5, (16) (17) . In this regard, we have previously shown a dedifferentiation of Schwann cells, as well as an activation of the Hedgehog signalling pathway, during malignant transformation of plexiform neurofibromas (18) .
TWIST1, an important transcription factor involved in embryonic development and in EMT, was shown to be up-regulated in NF1-associated MPNST (19) . Taken together, these findings Wnt pathway is a major developmental pathway involved in maintenance of normal stem cells (20) , and altered in several human cancers (21) . Wnt signalling is a complex process that requires interplay of many different proteins. In addition to a large cohort of Wnt ligands, and frizzled receptors, some Wnt pathways also require the presence of co-receptors. Wnt ligands may activate three different pathways ( Supplementary Fig. S1 ), (i) the canonical pathway: involving beta-catenin and LEF/TCF transcription factor, (ii) the planar cell polarity pathway, and (iii) the Wnt/calcium pathway (20, 22) . All three pathways have different consequences and drive specific processes for the cells in which they signal.
Little is known of the additional cooperating genetic events potentially required for full plexiform neurofibroma formation. Furthermore, the respective tumorigenic mechanisms of dermal neurofibromas and plexiform neurofibromas have rarely been compared (6) . In this manuscript we addressed the potential role of Wnt signalling in NF1 tumorigenesis. We here quantified the gene expression profiles of 89 actors of Wnt pathway in NF1-associated tumors. We identified specific genes involved in Wnt signalling pathway whose expressions significantly differed between three NF1-associated tumor types: dermal and plexiform neurofibromas and MPNSTs. We functionally confirmed the crosslink between NF1 alteration and Wnt pathway activation, using siRNA strategy in a cell line model. Finally, we investigated the link between Wnt signalling pathway activation and the altered expression of stemness and SMT genes.
MATERIALS AND METHODS

Patients and Samples
NF1-related samples were obtained by laser excision (dermal neurofibromas) or surgical excision (plexiform neurofibromas and MPNSTs) from patients with NF1 at Henri Mondor 9 hospital (Creteil, France). Sample handling and processing was identical for all NF1-related tumors. After clinical examination, the surgical removal of dermal neurofibromas was proposed in case of esthetical burden. Resection or removal of plexiform neurofibromas was proposed for repair or in case of symptoms, pain or compression. The plexiform neurofibromas (deep lesions involving a plexus of nerves) were large, had a nodular aspect, and severely deformed the affected tissues. They were all S100-positive by immunostaining.
Four patients with plexiform neurofibromas had developed MPNSTs. The main clinical and histological characteristics of the 16 patients with MPNSTs (validation set) are shown in Supplementary Table S1 . Immediately after surgery the tumor samples were flash-frozen in liquid nitrogen and stored at -80°C until RNA extraction. NF1-related MPNSTs all arose from plexiform neurofibromas and showed very weak S100 immunostaining (data not shown). MPNST samples from non-NF1 patients were obtained by surgical excision at Cochin hospital (Paris, France). Dermal neurofibromas were used as "normal" control samples as they never undergo malignant transformation in MPNSTs. Indeed, neurofibromas are heterogeneous benign tumors composed of Schwann cells, fibroblasts, mast cells and other cells, and have no "normal" tissue equivalent. Gene expression levels determined by real-time RT-PCR analysis in plexiform neurofibromas and MPNSTs were thus expressed relative to expression levels in dermal neurofibromas.
Cell Lines
We analyzed seven human MPNST cell lines, namely NMS-2, NMS-2PC, 88-3, ST88-14, 90-8, S462 and T265. NMS-2, and NMS-2PC were kind gifts from Dr. Akira Ogose (Niigata University School of Medicine, Niigata, Japon). 88-3, ST88-14, and 90-8 were kind gifts from Dr. Nancy Ratner (Cincinnati Children's Hospital Medical Center, Cincinnati, USA).
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MPNST cell lines were grown in RPMI medium supplemented with 10% heat-inactivated foetal bovine serum (FBS), 10 IU/ml penicillin and 10 µg/ml streptomycin. Normal Schwann cells and fibroblasts were obtained by primary cell culture and differential isolation from normal sciatic nerve biopsies and skin, respectively, and using cell culture and isolation conditions as previously described (23) (24) (25) . Normal mast cells were obtained by means of cell culture and various specific purification steps from cord blood-derived human cells, as previously described (26) .
We functionally analysed the crosslink between NF1 alteration and the Wnt pathway, using siRNA strategy in the mouse Schwann cell line MSC80. MSC80 cells exhibit normal Schwann cell characteristics [S100, myelin protein zero (MPZ), peripheral myelin protein 22 (PMP22) expression] and have retained the capacity to myelinate axons (27) . The mouse Schwann cell line MSC80 was maintained in Dulbecco's minimal essential medium (DMEM) supplemented with 10% decomplemented fetal calf serum (Hyclone-Perbio), 1% penicillin, 1% streptomycin (Gibco), and 1% glutamine. Culture cells were grown at 37°C in a humidified atmosphere of 5% CO 2 . A siRNA strategy was also used in two human non- Research.
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The theoretical and practical aspects of real-time quantitative RT-PCR using the ABI Prism 7900 Sequence Detection System (Perkin-Elmer Applied Biosystems) have been described in detail elsewhere (28 suggesting that primer-dimer formation and genomic DNA contamination effects were negligible. RNA extraction, cDNA synthesis and PCR reaction conditions have been described elsewhere (29) .
Immunohistochemical study
Formalin fixed, paraffin embedded skin samples were retrieved from the archive material of the department of Pathology of Henri Mondor hospital. Hematoxylin-eosin-saffron (HES) staining and immunohistochemistry were applied to 3 micrometer-thick dewaxed sections.
Research.
on April Immunostaining of beta-catenin (BD Biosciences Pharmingen) was done using the Bond max device (Menarini diagnostics, France), at a 1:4000 dilution after antigen retrieval by heat at pH 9. In all samples, we checked the staining of epithelial (epidermis or adnexae) and/or endothelial cells as internal positive controls.
HEK293, MCF-7, and MSC80 cells transfection with siRNA
To knockdown the NF1 gene, human cell lines (HEK293, and MCF-7) and mouse cells (MSC80) transient transfections were carried out using Effecten reagent (Qiagen) for MSC80, and Hiperfect Transfection Reagent (Qiagen) according to HiPerFect Transfection Reagent Handbook for human cell lines. SiRNAs were purchased from Qiagen: mouse siRNA against Nf1 (reference GS18015), human siRNA against NF1 (reference GS4763) and non-targeted (NT) siRNAs (negative control reference 1027310). Mouse Nf1 and human NF1 genes were targeted with four different sequences of siRNA directed against four different regions of the cognate mRNA. We quantified gene expressions at both mRNA (using realtime RT-PCR) and protein (using western blot) levels to assess the siRNAs efficacy.
Luciferase reporter assay of beta-catenin-mediated Wnt signalling pathway activation
Luciferase reporter assay was used to determine the Wnt pathway signaling activity in Nf1 14 activity was determined using an enzymatic method described by Massaad et al. (30) . The β-galactosidase activity was used for the transfection efficiency normalization.
Protein extraction and Western blot analysis
Cells transfected with NT siRNA or with siRNAs against NF1, were homogenized in 100 µl ice-cold RIPA buffer [50 mMTrisHCl Primary antibodies against neurofibromin (rabbit monoclonal antibody) were purchased from Santa-Cruz (reference sc67), mouse total beta-catenin (mouse monoclonal antibody) was
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purchased from BD Biosciences, human total β-catenin (rabbit polyclonal antibody) was purchased from Cell Signaling (reference #9562), active-betacatenin (mouse monoclonal antibody) and GAPDH (mouse monoclonal antibody) were purchased from Millipore (reference 05-665 and G8795). Secondary antibodies used for Western blotting were HRPconjugated goat anti-mouse and anti-rabbit IgG (Millipore).
Statistical Analysis
As mRNA levels did not fit a Gaussian distribution, (i) mRNA levels in each subgroup of samples were expressed as their median values and ranges, rather than their mean values and coefficients of variation and (ii) comparison and relationships between mRNA levels of the different target genes were respectively estimated using nonparametric tests: the MannWhitney U test (link between one qualitative parameter and one quantitative parameter) and the Spearman correlation test (link between two quantitative parameters). Differences between the two populations were judged significant at confidence levels greater than 95% (P < 0.05). In the SuperTOP-Flash Luciferase reporter assay, two groups comparisons were performed by the Student T test. A P-value of < 0.05 was considered to be statistically significant. Twenty (62.5%) of the 32 genes were significantly deregulated in the 16 MPNSTs as compared to the 10 dermal neurofibromas (P < 0.05; Fig. 1 
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LEF/TCF-inducible proteins (ID2, MSX2, SOX9, WISP1, TWIST1, and BMP2) and two proteins involved in the Wnt/calcium pathway (CAMK2B and PRKCQ).
Taken together, our results showed that four genes were specifically deregulated in plexiform neurofibromas, 15 were specifically dysregulated in MPNSTs, and five were dysregulated in both tumor types.
In the same set of 57 samples, we also examined the expression of the NF1 gene, and the proliferation-associated gene MKI67 which encodes the proliferation-related antigen Ki-67.
NF1 expression was similar in the three groups of tumors while MKI67 showed significant overexpression (30.5-fold) in MPNSTs (P = 0.00005; Fig.1, Supplementary Table S4 ). This lack of expression difference for NF1 is probably due to the fact that the NF1 gene is ubiquitously expressed and therefore expressed in the different cell components of the neurofibromas and MPNSTs, and that NF1 -/-Schwann cells represent only a fraction of the total Schwann cell population in tumor samples.
The immunohistochemical study of beta-catenin in MPNSTs showed a strong diffuse and cytoplasmic staining (Fig. 2) . In contrast, a weaker beta-catenin staining was observed in the plexiform neurofibromas (Fig. 2) .
mRNA expression of 32 identified Wnt pathway genes in paired plexiform neurofibroma and MPNST samples from four patients
We analyzed the mRNA levels of the 32 deregulated genes identified by "screening set"
analysis in four patients from whom both plexiform neurofibroma and matched MPNST samples were available. We found a clear decrease in the mRNA level of WNT9A, DKK3, SFRP4 (all patients), and WISP1 (patients 1, 3, and 4), upon progression from plexiform neurofibroma to MPNST (Supplementary Fig. S2 ). We also found a clear increase in the mRNA level of DKK1 (all patients), TLE2, TCF7, WNT2 (patients 1, 2, and 3), and WNT5A
(patients 3 and 4) during this transition ( Supplementary Fig. S2 ).
mRNA expression of the 24 differentially expressed Wnt pathway genes in four non-
NF1 (sporadic) MPNSTs
The expression levels of the 24 differentially expressed Wnt pathway genes were also determined in four non-NF1 (sporadic) human MPNST biopsies (Supplementary Table S5 ).
According with the data obtained in NF1-associated MPNSTs, the majority of the 14 genes up-regulated and of the six down-regulated in MPNST biopsies showed a trend to be also upand down-regulated. explain its expression profile in NF1 tumors, in particular its overexpression in plexiform neurofibromas (well-known to be more angiogenic than the dermal neurofibromas).
mRNA expression of the 24 differentially expressed Wnt pathway genes in seven NF1-associated MPNST cell lines
The expression levels of the 24 identified genes was determined in seven well-characterized NF1-associated MPNST cell lines, namely NMS-2, NMS-2PC, 88-3, ST88-14, 90-8, S462, and T265 (Table 2 ). All genes (except WT9A in agreement with the fact that it is an endothelial cell-specific gene) were expressed (Ct < 32) in at least one NF1-associated MPNST cell line. According with the data obtained in MPNSTs, the majority of the 14 genes up-regulated and of the six down-regulated in MPNST biopsies was also up-and down- 
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statistical significant positive association between SLUG and both PROM1 and NKX2-2 (P = 0.0033 and P = 0.00068, respectively).
In vitro consequences of NF1 inactivation on Wnt pathway activation state
To analyze the effects of the NF1 gene inactivation on the Wnt pathway, we knocked-down the expression of NF1 in two human cell lines (an embryonic kidney cell line: HEK293 and a breast adenocarcinoma cell line: MCF-7) and one mouse Schwann cell line (MSC80) by siRNAs strategy. Cells were transfected with either a non targeting siRNA (NT) or a siRNA directed against NF1. The efficacy of the knockdown of the NF1 expression was tested by real-time RT-PCR and western blot. In MSC80 cell line, we found a decreased Nf1 expression at both mRNA and protein (neurofibromin) levels (Fig. 3A) . In human cell lines (HEK293, and MCF-7), a decreased NF1 expression was confirmed at mRNA level (data not shown).
In the two human cell lines (HEK293, and MCF-7) mRNA expression of 24 Wnt pathway genes (cf. supra) was analysed after the knock-down of NF1. Those two non-Schwann cell lines showed no clear Wnt gene expression difference for the majority of the 14 up-regulated and the six down-regulated genes in MPNST biopsies and no difference was found in the amount of the active as well as the total beta-catenin quantified by WB (data not shown).
Similarly, no clear expression difference was found between the MEFs derived from wild type mice and the MEFs derived from Nf1 -/-mice, in the majority of the 14 up-regulated and of the six down-regulated genes in MPNST biopsies (data not shown).
In MSC80 Schwann cells, we used a Wnt pathway reporter assay to determine whether the canonical Wnt signaling pathway was modulated after the knock-down of Nf1. The silencing of Nf1 increased by 3-folds (P < 0.01) the promoter activity of SuperTOP-Flash-Luc in MSC80 (Fig. 3B) . The knock-down of Nf1 did not alter the promoter activity of SuperFOP- 
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). Furthermore, the transcript of Axin2, a target gene of Wnt pathway was increased by 2-folds after the silencing of Nf1 in MSC80 cells (Fig. 3C) . To assess whether the knockdown of Nf1 altered the expression of beta-catenin at the protein level, we have quantified by WB the amount of the active as well as the total beta-catenin. In MSC80 transfected with the siRNA against Nf1 we observed a 2-folds increase of the ratio of active-beta-catenin/totalbeta-catenin compared the control cells (Fig. 3D) .
Altogether, those data show that the knockdown of NF1 in Schwann cells enhances the activity of Wnt/beta-catenin pathway. Those data suggest cell-type-specific consequences of NF1 knockdown as Wnt pathway activation was not observed in epithelial (MCF-7) or kidney (HEK293) cell lines, or in MEFs cells but only in Schwann (MSC80) cell lines.
DISCUSSION
WNT signalling pathway orchestrates highly complex molecular events. Aberrant activation of Wnt pathway could trigger cell malignant transformation. In the last 20 years, involvement of the Wnt pathway has mainly been revealed in human epithelial malignancies (31).
However, the Wnt pathway may also play a role in tumors of mesenchymal origin (32) .
Mesenchymal stem cells could differentiate into Schwann cell-like cells (33) . In the present work, we therefore apprehended the role of Wnt pathway in NF1 tumorigenesis and more particularly its link with cancer stem cells and putative Schwann-mesenchymal transition.
Wnt pathway is tightly implicated in the myelination process elicited by Schwann cells. We have shown that the selective inhibition of Wnt components by siRNA or dominant negative forms inhibits the expression of myelin genes in mouse Schwann cells (34) (35) . Moreover, the 
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compaction in the central and peripheral nervous systems. Inhibition of Wnt/beta-catenin signaling resulted in hypomyelination, without affecting Schwann cells and oligodendrocytes generation or axonal integrity (21) . Thus, the dysregulation of this pathway could lead to either developmental defects or tumorigenesis.
Nine genes were significantly deregulated in plexiform neurofibromas (as compared to dermal neurofibromas): eight genes were up-regulated and one was down-regulated (Table   4 ). All these genes (except WNT9A, which seems endothelial cell-specific) were expressed in normal and tumoral Schwann cells (Table 2 ). Our results show that among the three different Wnt pathways, the canonical Wnt pathway is mainly involved in plexiform neurofibroma development with deregulation of genes encoding major components of this Wnt pathway (Table 4) . Little is known about the relevance of these genes (except MYC) to cancer biology.
A few observations have however described implications of these genes in several cancer types (36) (37) (38) (39) (40) . Taken together, these findings suggest an alteration of the canonical Wnt pathway FZD1/SFRP1/TLE2/MYC in plexiform neurofibroma development.
Our results also showed a major activation of the Wnt canonical pathway during the malignant transformation of plexiform neurofibromas in MPNSTs from NF1 patients. Indeed, 20 genes were significantly deregulated in the 16 NF1-related MPNSTs and the seven MPNST cell lines ( Fig. 1; Supplementary Table S4 ). These deregulated genes encode molecules mainly involved in the canonical Wnt pathway (Table 4) . Among them, TWIST1 and more recently SOX9 have already been identified as major genes involved in NF1 tumorigenesis (19, 41) . By using immunohistochemical analysis, we confirmed an activation of the Wnt canonical pathway during the malignant transformation of plexiform neurofibromas in MPNSTs from NF1 patients (Fig. 3) .
Wnt pathway expression analysis in a small set of non-NF1 (sporadic) MPNSTs also suggested an activation of the canonical Wnt pathway, as in the NF1-related MPNSTs. Our (43) (44) (45) . Moreover, STI-571 (Glivec) a tyrosine kinase inhibitor, down-regulates the β-catenin signalling activity and suppresses cell proliferation (46) . Finally, additional studies showed that RAS pathway activation can strongly cooperate with Wnt signalling to drive development of several type of carcinoma in vivo (47) (48) , and that PI3K/AKT pathway can regulate Wnt signalling in various cancers (49) . Our study emphasizes the potential cooperative link between Wnt pathway and RAS/MAPK and PI3K/AKT signalling pathways in NF1-associated tumorigenesis. In order to translate our observations into potential therapies, further studies will crucial to know which pathway(s) are critical for this link.
We confirmed the NF1/WNT pathway crosstalk at the functional level. We showed that the silencing of the Nf1 gene stimulated Wnt pathway activation in Schwann cell lines, as in an in vitro model. Nf1 knockdown induced (i) a Wnt pathway luciferase reporter assay activation, and (ii) an increased active-beta-catenin/total-beta-catenin ratio (Fig. 3) . Our data also suggest Schwann-cell-specific consequences of NF1 knockdown as no significant Wnt gene 
34
either NT or a siRNA against Nf1. Total RNA was extracted and RT-qPCR was performed using specific primer recognizing Axin2. (D) Western blots were performed using anti-active (dephosphorylated beta-catenin) and anti-total beta-catenin antibodies. GAPDH was used to normalize the Western blots. The western blots were quantified using Image J software (rsb.info.nih.gov).
Research. For each gene, mRNA levels were normalized to the 10 dermal neurofibromas. The gene mRNA levels (calculated as described in Materials and Methods) were based on the amount of the target message relative to the endogenous control TBP message, in order to normalize the starting amount and quality of total RNA. Similar results were obtained with a second endogenous control, the RPLP0 gene (also known as 36B4). Genes indicated in bold were found to be highly expressed as compared to one or several other normal human cells.
Research. • Wnt/calcium pathway: downregulated genes:
WNT9A
The genes indicated in bold were found altered both in plexiform neurofibromas and in MPNSTs.
